Giant Acral Melanoma on the Left Thumb of a Korean Patient
- Authors
- Kim, Jae Hwan; Jeong, Se Yeong; Shin, Jae Bin; Ro, Ki Woong; Seo, Soo Hong; Son, Sang Wook; Kim, Il-Hwan
- Issue Date
- 5월-2009
- Publisher
- KOREAN DERMATOLOGICAL ASSOC
- Keywords
- Bone invasion; Interferon-alpha-2a; Lymph node metastasis; Melanoma
- Citation
- ANNALS OF DERMATOLOGY, v.21, no.2, pp.171 - 173
- Indexed
- SCIE
SCOPUS
KCI
OTHER
- Journal Title
- ANNALS OF DERMATOLOGY
- Volume
- 21
- Number
- 2
- Start Page
- 171
- End Page
- 173
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/120118
- DOI
- 10.5021/ad.2009.21.2.171
- ISSN
- 1013-9087
- Abstract
- The acral regions of the limbs of Asians are predisposed to develop malignant melanoma, but giant-sized acral melanoma has not been previously reported in the Asian population. Giant-sized melanoma implies aggressive tumor invasion and so it is more difficult to achieve a therapeutic cure. A 56-year-old woman presented with a giant acral melanoma of the left thumb with concomitant bone destruction and axillary lymph node metastasis. The initial lesion was a subungual black macule on the left thumb that had grown into a giant 7.0x4.0x3.5 cm-sized melanoma over a 3 year period. The left thumb was amputated and the axillary lymph nodes were completely dissected. During the ensuing 3 months, she underwent adjuvant treatment with interferon-alpha-2a. The interesting feature of this case is that the large melanoma mass of this patient, which was accompanied with adjacent bone destruction and lymph node metastasis, had developed rapidly from a small black macule in the nail matrix, and this black macule was suspected to be a subungual melanoma. (Ann Dermatol 21(2) 171 similar to 173, 2009)
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Graduate School > Department of Biomedical Sciences > 1. Journal Articles
- College of Medicine > Department of Medical Science > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.